Share on LinkedInShare on LinkedIn

ARTICLE · 20 MAY 2024

Private Equity Firm Welsh Carson Dismissed From FTC Antitrust Action

In Federal Trade Commission v. U.S. Anesthesia Partners, Inc. et al., No. 4:23-CV-03560 (S.D. Tex. May 13, 2024), the court granted private equity firm Welsh, Carson, Anderson & Stowe's...

United StatesAntitrust/Competition Law

Highlights

  • In Federal Trade Commission v. U.S. Anesthesia Partners, Inc. et al., a federal district court granted private equity firm Welsh, Carson, Anderson & Stowe's motion to dismiss it from the Federal Trade Commission's (FTC) lawsuit alleging an anticompetitive scheme to drive up the price of anesthesia services by orchestrating a decade-long "roll-up" strategy to consolidate anesthesiology practices in Texas. However, the court denied U.S. Anesthesia Partners' motion to dismiss.
  • Section 13(b) of the FTC Act does not permit the FTC to seek injunctive relief on "long-past conduct" without some evidence that a defendant "is" committing or "is about to" commit another violation of the law.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from